Colgate-Palmolive (NYSE:CL) Earns Market Perform Rating from Analysts at Wolfe Research

Wolfe Research started coverage on shares of Colgate-Palmolive (NYSE:CLGet Rating) in a research report report published on Monday morning, MarketBeat reports. The brokerage issued a market perform rating on the stock.

A number of other analysts also recently issued reports on CL. JPMorgan Chase & Co. upgraded shares of Colgate-Palmolive from a neutral rating to an overweight rating and set a $79.00 price target for the company in a report on Thursday, October 13th. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $80.00 to $75.00 and set an equal weight rating for the company in a report on Monday, October 3rd. Barclays lifted their target price on shares of Colgate-Palmolive from $72.00 to $76.00 and gave the company an equal weight rating in a report on Tuesday, November 1st. The Goldman Sachs Group dropped their target price on shares of Colgate-Palmolive from $91.00 to $81.00 and set a buy rating for the company in a report on Monday, October 10th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $90.00 to $80.00 in a report on Thursday, October 13th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Hold and an average target price of $82.42.

Colgate-Palmolive Stock Up 0.7 %

Shares of NYSE CL opened at $76.93 on Monday. The company has a 50 day simple moving average of $73.21 and a 200-day simple moving average of $76.71. The company has a market capitalization of $64.25 billion, a P/E ratio of 33.45, a P/E/G ratio of 7.12 and a beta of 0.52. The company has a debt-to-equity ratio of 7.81, a current ratio of 1.17 and a quick ratio of 0.71. Colgate-Palmolive has a 1 year low of $67.84 and a 1 year high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings results on Friday, October 28th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. The business had revenue of $4.46 billion during the quarter, compared to the consensus estimate of $4.47 billion. Colgate-Palmolive had a net margin of 10.87% and a return on equity of 304.29%. The business’s revenue was up .9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.81 EPS. On average, equities research analysts predict that Colgate-Palmolive will post 2.97 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Friday, October 21st were given a dividend of $0.47 per share. The ex-dividend date of this dividend was Thursday, October 20th. This represents a $1.88 annualized dividend and a dividend yield of 2.44%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 81.74%.

Insider Transactions at Colgate-Palmolive

In other news, insider Prabha Parameswaran sold 48,778 shares of Colgate-Palmolive stock in a transaction on Monday, August 29th. The shares were sold at an average price of $78.80, for a total transaction of $3,843,706.40. Following the completion of the sale, the insider now directly owns 6,787 shares of the company’s stock, valued at approximately $534,815.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Sally Massey sold 656 shares of the business’s stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $77.58, for a total value of $50,892.48. Following the completion of the sale, the insider now directly owns 7,913 shares of the company’s stock, valued at $613,890.54. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Prabha Parameswaran sold 48,778 shares of the business’s stock in a transaction on Monday, August 29th. The shares were sold at an average price of $78.80, for a total transaction of $3,843,706.40. Following the completion of the sale, the insider now directly owns 6,787 shares of the company’s stock, valued at $534,815.60. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Institutional investors and hedge funds have recently bought and sold shares of the stock. TCI Wealth Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 76.0% in the second quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company’s stock valued at $25,000 after buying an additional 136 shares during the last quarter. Better Money Decisions LLC purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at about $25,000. Core Alternative Capital raised its holdings in shares of Colgate-Palmolive by 924.3% in the first quarter. Core Alternative Capital now owns 379 shares of the company’s stock valued at $29,000 after buying an additional 342 shares during the last quarter. Verity Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $29,000. Finally, Hallmark Capital Management Inc. raised its holdings in shares of Colgate-Palmolive by 158.2% in the third quarter. Hallmark Capital Management Inc. now owns 408 shares of the company’s stock valued at $29,000 after buying an additional 250 shares during the last quarter. 78.62% of the stock is owned by hedge funds and other institutional investors.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.